市場概要
精密医療を使用して病気の特徴を調べ、詳細な研究を行います診断する患者固有の情報に基づいて。このコンセプトは、分子バイオマーカー分析、次世代シーケンシング、バイオインフォマティクス、ビッグデータ分析などの先進技術の拡大を通じて医学界で急速に成長していることに基づいています。精密医療は、ゲノミクスと特定のバイオマーカー技術に依存することにより、さまざまな病気の診断と治療を可能にします。このアプローチにより、研究者や医師は、特定の病気の治療および予防戦略をより正確に予測できるようになります。
市場範囲スパン>
「2031 年までの世界の精密医療市場分析」は、世界市場の傾向分析に特に焦点を当てた、ヘルスケア業界の専門的で詳細な調査です。このレポートは、技術、アプリケーション、地域ごとに詳細な市場分割を行い、精密医療市場の概要を提供することを目的としています。このレポートは、精密医療市場の主要プレーヤーの市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。
市場セグメンテーション
- テクノロジーに基づいて、世界の精密医療市場はビッグデータ分析、バイオインフォマティクス、遺伝子配列決定、創薬、コンパニオン診断、その他のテクノロジーに分割されています。
- 世界の精密医療市場は、アプリケーションに基づいて、腫瘍学、CNS、免疫学、呼吸器、その他のアプリケーションに分類されます。
市場ダイナミクス
ドライバー
- 慢性疾患の有病率の増加
- がん生物学の進歩
- バイオテクノロジー分野での研究開発活動の増加
- 計算ツールと組み合わせた大規模なヒトゲノム データベースの利用可能性
拘束
- FDA の薬物療法承認率の低下
地域フレームワーク
このレポートは、定性的および定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいた世界市場の概要と予測を提供します。また、市場規模も提供します。北米、欧州、アジア太平洋(APAC)、中東およびアフリカ(MEA)、南米の5つの主要地域について、2021年から2031年までの予測推計を地域ごとにまとめています。その後、それぞれの国とセグメントごとにサブセグメント化されます。このレポートでは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会が取り上げられています。
レポートは、需要側と供給側の両方から市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場のダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートでは、北米、ヨーロッパ、APAC、MEA、南米の 5 つの地域すべてについて、これらの地域の精密医療市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後、徹底的な PEST 分析も提供しています。 p>
精密医薬品市場に対する新型コロナウイルス感染症 (COVID-19) の影響
新型コロナウイルス感染症は、ロックダウン、渡航禁止、事業停止により、さまざまな国の経済と産業に影響を与えています。医療業界は、精密医療とゲノミクス研究を実施して、新型コロナウイルス感染症 (COVID-19) は、潜在的な治療法に影響を与え、発見しています。精密医療は政府間の協力的な取り組みを促進しており、製品の発売の増加が市場の成長を推進しています。たとえば、2021 年 10 月に、ダイアシューティクス PLC は DXRX 診断ネットワークを立ち上げました。それは次のように設計されています。がん検査におけるバイオマーカー検査の採用のピークまでの時間を数年から数か月に短縮することで、高精度医療診断のエンドツーエンドの開発と商品化を加速します。
市場参加者
このレポートでは、有機的および無機的な成長戦略として精密医療市場の主要な展開について取り上げています。さまざまな企業が、製品の発売、製品の承認などの有機的な成長戦略に焦点を当てています。特許とイベント市場で目撃された無機成長戦略活動は買収、パートナーシップとコラボレーションでしたこれらの活動は、市場プレーヤーのビジネスと顧客ベースの拡大への道を切り開きました精密医療市場の市場支払者は、有利な成長機会が期待されています
レポートには、精密医療市場における主要企業の SWOT 分析と市場戦略とともに、主要企業のプロフィールも含まれています。さらに、レポートは、次のような情報を提供する業界の主要企業に焦点を当てています。会社概要、コンポーネント、提供されるサービス、過去 3 年間の財務情報、過去 5 年間の主要な開発など。
- F. Hoffmann-La Roche Ltd
- Quest Diagnostics Incorporated
- Novartis AG
- ブリストル・マイヤーズ スクイブ社
- メドトロニック
- QIAGEN
- ファイザー株式会社
- サーモフィッシャーサイエンティフィック株式会社
- イーライ リリー アンド カンパニー
- アストラゼネカ
Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査にさまざまなカスタマイズ オプションを提供します。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to register a CAGR of 11.3% during 2023–2031.
Rapidly rising healthcare expenditure, advancement in genetic testing, migration towards personalized treatments, and integration of big data and AI in healthcare are the prime growth factors for Precision Medicine Market.
Future trends include increased use of genomic data in developing tailored treatments, expansion of personalized cancer therapies, and increased integration of AI and machine learning in drug development.
The leading players are F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Novartis AG, Bristol-Myers Squibb Company, Medtronic, QIAGEN, Pfizer Inc., Thermo Fisher Scientific Inc., Eli Lilly and Company, AstraZeneca,
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies
1. F. Hoffmann-La Roche Ltd
2. Quest Diagnostics Incorporated
3. Novartis AG
4. Bristol-Myers Squibb Company
5. Medtronic
6. QIAGEN
7. Pfizer Inc.
8. Thermo Fisher Scientific Inc.
9. Eli Lilly and Company
10. AstraZeneca
11. OneOme LLC
12. Kailos Genetics Inc.
13. Syapse Inc.
14. BioSyntagma
15. Biogen
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.